CD69 and neoplasm: A significant increase in T-cell activation was seen, as detected by an increase in CD69 expression on CD4+ and CD8+ T cells, as well as a marked increase in human leukocyte antigen (HLA) class I expression on tumor cells, consistent with increased antigen presentation and susceptibility to immune-mediated killing.